Influence on quality of life from an early cinacalcet prescription for secondary hyperparathyroidism in dialysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|24|2|187-196

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.2, 2015-02, pp. : 187-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet

By Belozeroff Vasily   Lee Andrew   Tseng Spring   Chiroli Silvia   Campbell Jonathan D.  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1154-1162

Informa Healthcare

Access to resources Recommend Favorite

Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients – Results of the Austrian cohort of the ECHO study

By Zitt Emanuel  

Wiener klinische Wochenschrift, Vol. 123, Iss. 1-2, 2011-01 ,pp. : 45-52

Springer Publishing Company

Access to resources Recommend Favorite

Cinacalcet Treatment for Secondary Hyperparathyroidism in Dialysis Patients: An Observational Study in Routine Clinical Practice

By  

Nephron Clin Pract, Vol. 118, Iss. 2, 2010-12 ,pp. : c109-c121

Karger

Access to resources Recommend Favorite

Response of Secondary Hyperparathyroidism to Cinacalcet Depends on Parathyroid Size

By  

Nephron Clin Pract, Vol. 114, Iss. 3, 2009-11 ,pp. : c187-c193

Karger

Access to resources Recommend Favorite

Comparative Effectiveness of Paricalcitol versus Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

By  

Nephron Clin Pract, Vol. 117, Iss. 2, 2010-08 ,pp. : c151-c159

Karger

Access to resources Recommend Favorite